Protalix BioTherapeutics, Inc. (PLX) Operating Income (Loss) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
  • Protalix BioTherapeutics, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$4.86 M, a 97.5% decline year-over-year.
  • Protalix BioTherapeutics, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was $8.06 M.
  • Protalix BioTherapeutics, Inc. annual Operating Income (Loss) for 2023 was $10.5 M.
  • Protalix BioTherapeutics, Inc. annual Operating Income (Loss) for 2022 was -$13 M, a 36.4% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Operating Income (Loss) for 2021 was -$20.5 M, a 855% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $8.06 M -$4.86 M -$2.4 M -97.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $10.5 M -$5.62 M -$3.12 M -125% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $13.6 M -$1.89 M +$1.24 M +39.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $12.3 M $20.4 M +$25.9 M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 -$13.6 M -$2.46 M -$589 K -31.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$13 M -$2.5 M +$3.21 M +56.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$16.2 M -$3.13 M -$1.24 M -65.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$15 M -$5.52 M +$3.64 M +39.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$18.6 M -$1.87 M +$1.84 M +49.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$20.5 M -$5.71 M -$8.55 M -301% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 -$11.9 M -$1.89 M +$697 K +27% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$12.6 M -$9.17 M -$6.93 M -309% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$5.69 M -$3.71 M -$8.4 M -179% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $2.71 M $2.84 M +$639 K +29% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $2.07 M -$2.58 M -$1.04 M -67.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $3.11 M -$2.24 M +$3.6 M +61.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$490 K $4.69 M +$10.2 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$10.7 M $2.2 M +$5.87 M Oct 1, 2019 Dec 31, 2019 10-K 2020-03-12
Q3 2019 -$16.6 M -$1.54 M +$2.2 M +58.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 -$18.8 M -$5.84 M +$905 K +13.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$19.7 M -$5.53 M -$383 K -7.44% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-01
Q4 2018 -$19.3 M -$3.67 M +$5.91 M +61.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$25.2 M -$3.74 M +$4.02 M +51.8% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$29.2 M -$6.74 M +$4.06 M +37.6% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$33.3 M -$5.15 M +$1.21 M +19.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$34.5 M -$9.58 M -$862 K -9.89% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 -$33.7 M -$7.77 M -$1.12 M -16.8% Jul 1, 2017 Sep 30, 2017 10-Q/A 2019-03-18
Q2 2017 -$32.5 M -$10.8 M -$874 K -8.8% Apr 1, 2017 Jun 30, 2017 10-Q/A 2019-03-18
Q1 2017 -$31.7 M -$6.37 M +$1.5 M +19.1% Jan 1, 2017 Mar 31, 2017 10-Q/A 2019-03-18
Q4 2016 -$33.2 M -$8.72 M -$1.02 M -13.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 -$32.1 M -$6.65 M -$1.65 M -32.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$30.5 M -$9.93 M -$4.35 M -77.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$26.2 M -$7.86 M -$2.48 M -46.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$23.7 M -$7.7 M +$2.74 M +26.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 -$26.4 M -$5 M +$1.21 M +19.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$27.6 M -$5.58 M -$137 K -2.52% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$27.5 M -$5.38 M +$1.08 M +16.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$28.6 M -$10.4 M +$6.66 M +39% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$35.2 M -$6.21 M -$563 K -9.97% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$34.7 M -$5.45 M +$1.45 M +21% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$36.1 M -$6.47 M -$2.04 M -46% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$34.1 M -$17.1 M -$6.93 M -68.1% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-08
Q3 2013 -$27.1 M -$5.65 M -$85 K -1.53% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$27.1 M -$6.89 M -$16.5 M -172% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$10.5 M -$4.43 M +$1.64 M +27% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$12.2 M -$10.2 M -$1.31 M -14.8% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 -$10.9 M -$5.56 M +$3.21 M +36.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$14.1 M $9.62 M +$23.5 M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$37.6 M -$6.07 M -$1.03 M -20.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$36.5 M -$8.86 M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 -$8.77 M -$5.92 M -208% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 -$13.9 M -$3.72 M -36.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 -$5.04 M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$2.85 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$10.2 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.